NI
MDT icon

Natural Investments’s Medtronic MDT Stock Holding History

Natural Investments’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$278K Sell
3,555
-2,255
-39% -$182K 0.06% 241
2026
Q1 		$503K Buy
5,810
+909
+19% +$87.1K 0.12% 161
2025
Q4 		$470K Buy
4,901
+762
+18% +$74K 0.12% 166
2025
Q3 		$394K Buy
4,139
+82
+2% +$7.54K 0.1% 160
2025
Q2 		$353K Buy
4,057
+398
+11% +$33.8K 0.09% 186
2025
Q1 		$328K Buy
3,659
+15
+0.4% +$1.34K 0.09% 182
2024
Q4 		$291K Buy
+3,644
New +$315K 0.08% 196

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Natural Investments's MDT Position: Q2 2026 in Review

Natural Investments reduced its Medtronic (MDT) stake by 39% in Q2 2026, selling an estimated $182K and leaving 3,555 shares worth $278K. The position accounts for 0.06% of the portfolio, ranked #241.

Natural Investments first reported a position in MDT in Q4 2024 and has held it in 7 quarters since. The position peaked at $503K in Q1 2026. 1,329 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Natural Investments held 3,555 shares of Medtronic worth $278K as of Q2 2026.
  • Natural Investments sold 2,255 Medtronic shares in Q2 2026, an estimated $182K.
  • Medtronic made up 0.06% of Natural Investments's portfolio in Q2 2026, its #241 holding.
  • Natural Investments first reported a position in Medtronic in Q4 2024 and has held it in 7 quarters since.
  • Natural Investments's Medtronic position peaked at $503K in Q1 2026.
  • 1,329 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Natural Investments's 13F filing for Q2 2026, filed 31 Jul 2026.